Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
160,529,963
-
Number of holders
-
88
-
Total 13F shares, excl. options
-
42,085,723
-
Shares change
-
-6,577,739
-
Total reported value, excl. options
-
$85,856,544
-
Value change
-
-$11,439,635
-
Put/Call ratio
-
83%
-
Number of buys
-
32
-
Number of sells
-
-45
-
Price
-
$2.04
Significant Holders of Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) as of Q4 2023
106 filings reported holding GRTS - Gritstone bio, Inc. - Common Stock, $0.0001 par value per share as of Q4 2023.
Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) has 88 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42,085,723 shares
of 160,529,963 outstanding shares and own 26% of the company stock.
Largest 10 shareholders include Redmile Group, LLC (5,872,605 shares), BlackRock Inc. (5,868,353 shares), MORGAN STANLEY (5,520,453 shares), VANGUARD GROUP INC (4,416,292 shares), Point72 Asset Management, L.P. (3,974,867 shares), Versant Venture Management, LLC (3,561,150 shares), FMR LLC (1,985,294 shares), GEODE CAPITAL MANAGEMENT, LLC (1,905,773 shares), STATE STREET CORP (1,781,003 shares), and Frazier Life Sciences Management, L.P. (1,030,878 shares).
This table shows the top 88 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.